Bernstein Harold

CIK 00020501721 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0002050172

Recent Transactions

50 trades

Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-08-13$10.42/sh+16,142→ 16,142 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-08-13−16,142→ 176,803 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-08-13$27.61/sh−16,142→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-07-01$10.42/sh+14,609→ 14,609 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-07-01−14,609→ 192,945 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-07-01$30.34/sh−1,200→ 0 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-07-01$29.86/sh−13,409→ 1,200 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-06-01$25.57/sh−13,253→ 1,600 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-06-01−14,853→ 207,554 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-06-01$26.36/sh−1,600→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-06-01$10.42/sh+14,853→ 14,853 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-05-14−15,000→ 222,407 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-14$10.42/sh+15,000→ 15,000 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-05-14$26.22/sh−15,000→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-04-01−15,000→ 237,407 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-04-01$10.42/sh+15,000→ 15,000 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-04-01$29.24/sh−11,352→ 3,648 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-04-01$30.06/sh−3,348→ 300 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-04-01$31.07/sh−300→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-03-20−15,000→ 252,407 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-03-20$10.42/sh+15,000→ 15,000 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-03-20$48.20/sh−6,161→ 8,839 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-03-20$49.32/sh−3,795→ 5,044 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-03-20$50.02/sh−5,044→ 0 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-03-10$51.02/sh−348→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-03-10$10.42/sh+30,000→ 30,000 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-03-10$50.45/sh−29,652→ 348 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-03-10−30,000→ 267,407 total
Award
Maze Therapeutics, Inc.$MAZE
Restricted Stock Units
2026-03-02+24,000→ 24,000 total
Award
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-03-02+48,000→ 48,000 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$10.42/sh+15,000→ 15,000 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$46.37/sh−5,936→ 100 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$45.89/sh−8,364→ 6,036 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$44.20/sh−600→ 14,400 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-02-02−15,000→ 297,407 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-02-02$47.23/sh−100→ 0 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-07$40.20/sh−25,156→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-07−25,156→ 312,407 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-07$10.42/sh+25,156→ 25,156 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-05−412→ 337,563 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-05$40.00/sh−412→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-05$10.42/sh+412→ 412 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2026-01-02−4,432→ 337,975 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-02$10.42/sh+4,432→ 4,432 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2026-01-02$40.43/sh−4,432→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$10.42/sh+45,000→ 45,000 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$40.34/sh−27,800→ 17,200 total
Sale
Maze Therapeutics, Inc.$MAZE
Common Stock
2025-12-29$40.93/sh−17,200→ 0 total
Exercise/Conversion
Maze Therapeutics, Inc.$MAZE
Stock Option (Right to Buy)
2025-12-29−45,000→ 342,407 total
Award
Maze Therapeutics, Inc.$MAZE
Restricted Stock Units
2025-09-22+40,000→ 40,000 total

Companies

Maze Therapeutics, Inc.
President, R&D & CMO
$MAZE

Recent Filings

Address

C/O MAZE THERAPEUTICS, INC. 171 OYSTER POINT BOULEVARD, SUITE 300

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov